Literature DB >> 29575616

Autosomal dominant Robinow syndrome associated with a novel DVL3 splice mutation.

Magdalena Danyel1, Fanny Kortüm2, Katarina Dathe1,3, Kerstin Kutsche2, Denise Horn1.   

Abstract

Robinow syndrome is a clinically and genetically heterogeneous disorder characterized by mesomelic limb shortening, distinctive facial features, and variable oral, cardiac, vertebral, and urogenital malformations. We identified the novel de novo splice acceptor mutation c.1715-2A > C in DVL3 in a 15-year-old female patient with typical features of Robinow syndrome. By studying DVL3 transcripts in this patient, we confirmed expression of both wild-type and mutant alleles. Mutant DVL3 mRNAs were found to harbor a deletion of four nucleotides at the beginning of exon 15 and encode a protein product with a distinct -1 reading-frame C-terminus. The data demonstrate that mutant DVL3 proteins associated with Robinow syndrome show truncation of the C-terminus and share 83 novel amino acid residues before the stop codon confirming highly specific DVL3 alterations to be associated with this syndrome. The phenotype of the Robinow syndrome-affected female reported here is typical as she shows mesomelia and mild hand anomalies as well as characteristic facial anomalies. She also exhibited a supraumbilical midline abdominal raphe which has not been observed in other patients with Robinow syndrome. In contrast to the clinical data of four previously reported individuals with DVL3-related Robinow syndrome, short stature was not present in this individual at the age of 15 years. These findings expand the clinical spectrum of Robinow syndrome associated with DVL3 mutations. To date, comparison of clinical data of DVL3 mutation-positive individuals with those of patients with genetically different forms did not allow delineation of gene-specific phenotypes.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  DVL3; Robinow syndrome; Wnt signaling; autosomal dominant, DVL1

Mesh:

Substances:

Year:  2018        PMID: 29575616     DOI: 10.1002/ajmg.a.38635

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  5 in total

Review 1.  WNT Signaling and Bone: Lessons From Skeletal Dysplasias and Disorders.

Authors:  Yentl Huybrechts; Geert Mortier; Eveline Boudin; Wim Van Hul
Journal:  Front Endocrinol (Lausanne)       Date:  2020-04-09       Impact factor: 5.555

2.  3q27.1 microdeletion causes prenatal and postnatal growth restriction and neurodevelopmental abnormalities.

Authors:  Subit Barua; Elaine M Pereira; Vaidehi Jobanputra; Kwame Anyane-Yeboa; Brynn Levy; Jun Liao
Journal:  Mol Cytogenet       Date:  2022-03-03       Impact factor: 2.009

3.  Novel pathogenic genomic variants leading to autosomal dominant and recessive Robinow syndrome.

Authors:  Chaofan Zhang; Juliana F Mazzeu; Jesper Eisfeldt; Christopher M Grochowski; Janson White; Zeynep C Akdemir; Shalini N Jhangiani; Donna M Muzny; Richard A Gibbs; Anna Lindstrand; James R Lupski; V Reid Sutton; Claudia M B Carvalho
Journal:  Am J Med Genet A       Date:  2020-10-13       Impact factor: 2.802

4.  Novel pathogenic variants and quantitative phenotypic analyses of Robinow syndrome: WNT signaling perturbation and phenotypic variability.

Authors:  Chaofan Zhang; Angad Jolly; Brian J Shayota; Juliana F Mazzeu; Haowei Du; Moez Dawood; Patricia Celestino Soper; Ariadne Ramalho de Lima; Bárbara Merfort Ferreira; Zeynep Coban-Akdemir; Janson White; Deborah Shears; Fraser Robert Thomson; Sarah Louise Douglas; Andrew Wainwright; Kathryn Bailey; Paul Wordsworth; Mike Oldridge; Tracy Lester; Alistair D Calder; Katja Dumic; Siddharth Banka; Dian Donnai; Shalini N Jhangiani; Lorraine Potocki; Wendy K Chung; Sara Mora; Hope Northrup; Myla Ashfaq; Jill A Rosenfeld; Kati Mason; Lynda C Pollack; Allyn McConkie-Rosell; Wei Kelly; Marie McDonald; Natalie S Hauser; Peter Leahy; Cynthia M Powell; Raquel Boy; Rachel Sayuri Honjo; Fernando Kok; Lucia R Martelli; Vicente Odone Filho; Donna M Muzny; Richard A Gibbs; Jennifer E Posey; Pengfei Liu; James R Lupski; V Reid Sutton; Claudia M B Carvalho
Journal:  HGG Adv       Date:  2021-12-03

Review 5.  Genomic frontiers in congenital heart disease.

Authors:  Sarah U Morton; Daniel Quiat; Jonathan G Seidman; Christine E Seidman
Journal:  Nat Rev Cardiol       Date:  2021-07-16       Impact factor: 49.421

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.